Hello. We’re Lumonus, a company focused on transforming cancer care. Our origin stems from experiencing first-hand the challenges that Providers face in delivering quality cancer care across global markets. We understand what it’s like to be a Provider, from managing clinical teams, understanding the needs of the patients and dealing with payors. It’s a hard job! At Lumonus we see the opportunity to transform how cancer care is delivered by empowering care teams through our twofold focus of user centric software products and also providing value-added services. We believe in the power of teams and how together they can achieve exceptional goals. Our team draws from years of provider experience and recognises the real-world problems and unmet needs that clinics of all sizes encounter. We embrace innovative thinking and constantly search for new possibilities. Our Products and Services: Oncology Software, Remote Dosimetry, Physics Commissioning, Comprehensive Physics, Clinical and Operations strategy consulting Servicing regions: USA, Australia and UK
Location: Australia
Total raised: $25M
Funding Rounds 1
| Date | Series | Amount | Investors |
| 07.11.2025 | Series B | $25M | Oncology V... |
Mentions in press and media 5
| Date | Title | Description |
| 08.11.2025 | Lumonus Boosts AI Oncology with $25M Investment for US Expansion | Lumonus, an AI oncology leader, secured $25M in Series B funding. This investment boosts its cutting-edge AI platform globally. It targets US market expansion. The platform automates radiation oncology workflows. It improves cancer treatmen... |
| 07.11.2025 | Lumonus Raises A$25 Million in Series B to Scale AI Powered Oncology Workflows Globally | SYDNEY, Nov. 7, 2025 /PRNewswire/ -- Lumonus, a leader in AI powered radiation oncology workflow solutions, today announced the close of its A$25 million Series B financing round. The round was led by Aviron Investment Management with conti... |
| 07.11.2025 | Lumonus Raises $25M in Series B Funding | Lumonus, a Sydney, Australia-based company which specializes in AI powered radiation oncology workflow solutions, raised $25M in Series B funding. The round was led by Aviron Investment Management with continued participation from Oncology ... |
| 30.09.2025 | Lumonus Announces Transformative Multi-Year Licensing Agreement with Smarter Radiation Oncology® to bring evidenced-based directives to U.S. cancer centers | NEW YORK and SYDNEY, Sept. 30, 2025 /PRNewswire/ -- Lumonus, a healthcare technology company transforming cancer care with its AI-powered platform, today announced a multi-year agreement with Smarter Radiation Oncology® (SRO), a company inc... |
| - | Lumonous | “Lumonus” |